ocugen_4C_LOGO (002).png
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
June 21, 2024 07:00 ET | Ocugen
•  Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial•  DSMB Determination to Proceed with High Dose Cohort Dosing MALVERN, Pa., June 21, 2024 (GLOBE NEWSWIRE) --...
Adeno-associated Virus Gene Therapy Market
Adeno-associated Virus Gene Therapy Market Report 2024-2034: Epidemiology, Industry Trends and Forecasts
June 21, 2024 06:05 ET | Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Adeno-associated Virus Gene Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been...
Global CRISPR and Cas Genes Market
CRISPR and Cas Genes Market Research 2024 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F
June 20, 2024 07:24 ET | Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F" report has been added to ...
ocugen_4C_LOGO (002).png
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
June 20, 2024 06:30 ET | Ocugen
MALVERN, Pa., June 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
European Cell & Gene Therapy Market
Europe Cell & Gene Therapy Market Insights 2024-2029: Rising use of CGT Products for Disease Care, Funding Support in Europe for CGTs
June 20, 2024 04:06 ET | Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Europe Cell & Gene Therapy Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Europe Cell &...
22157.jpg
Exosome Therapeutics Pipeline research 2024
June 19, 2024 07:45 ET | Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Exosomes - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An array of drugs is currently moving through various...
22157.jpg
Global Cell and Gene Therapy Manufacturing Market Report 2024-2034 - A $124.45 Billion Opportunity with Roche, Hitachi Chemical, and Thermo Fisher Scientific Dominating
June 14, 2024 06:16 ET | Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Manufacturing Market Analysis & Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering.The...
22157.jpg
CRISPR Therapies Market Research 2024: Pipeline Analysis, Therapeutic Assessment, Unmet Needs, Impact of Drugs
June 14, 2024 06:15 ET | Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "CRISPR therapies - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "CRISPR Therapies - Pipeline...
22157.jpg
Cell and Gene Therapy Industry Analysis of Deal Activity from 2021 to 2024: Specific Details of 2000+ CGT Deals with Regional Breakdown of Dealmaking
June 10, 2024 11:50 ET | Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Deals Analysis, 2021-2024" report has been added to ResearchAndMarkets.com's offering. The Cell and Gene Therapy Deals...
22157.jpg
$43+ Billion Cell and Gene Therapy Clinical Trials Market Forecast, 2024-2034, by Therapy Type, Phase, Indication, and Region
June 05, 2024 03:41 ET | Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Clinical Trials Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...